Loading…
Clarivate Plc is projected to rise to $3.19 by 2027, a +23% move from its current price of $2.59. CLVT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.51 | $2.59 | $2.67 | +0.04% |
| May 30 | $2.48 | $2.59 | $2.71 | +0.08% |
| May 31 | $2.46 | $2.59 | $2.73 | +0.12% |
| Jun 1 | $2.44 | $2.59 | $2.76 | +0.16% |
| Jun 2 | $2.42 | $2.60 | $2.78 | +0.20% |
| Jun 3 | $2.41 | $2.60 | $2.80 | +0.24% |
| Jun 4 | $2.39 | $2.60 | $2.82 | +0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.39 | $2.60 | $2.82 | +0.28% |
| Week 2 | $2.32 | $2.60 | $2.92 | +0.57% |
| Week 3 | $2.27 | $2.61 | $3.01 | +0.85% |
| Week 4 | $2.23 | $2.62 | $3.08 | +1.14% |
| Week 5 | $2.19 | $2.63 | $3.15 | +1.43% |
| Week 6 | $2.16 | $2.63 | $3.22 | +1.72% |
| Week 7 | $2.13 | $2.64 | $3.28 | +2.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Clarivate Plc provides information services across the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries.
It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies.
The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Clarivate Plc (CLVT) is trading at $2.45 per share with a market cap of $1.57B, and it ranks 2195 by market capitalization. The current price sits below the 50-day moving average of $2.54 and well below the 200-day moving average of $3.19, signaling near-term weakness against the longer-term trend. The 30-day range is $1.99 to $3.01, with a near-term support at $2.27 and resistance at $2.87.
From a longer-term perspective, the forecast depicts a bullish path, with the average price rising from $2.45 in 2026 to $9.88 by 2050 and a max of $19.29 in 2050, implying potential ROIs up to 303.3% over the period.
A major floor 35.1% below — a decisive break under it would weaken the trend.
The nearest floor, 9.7% below — buyers have tended to step in here.
The nearest ceiling, 10.8% above — a clean break opens room to run.
A major ceiling 22.4% above — clearing it would confirm fresh momentum.
Key CLVT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLVT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.48 | Buy | $2.51 | Buy |
| MA 10 | $2.46 | Buy | $2.52 | Buy |
| MA 20 | $2.62 | Sell | $2.54 | Buy |
| MA 50 | $2.54 | Buy | $2.56 | Buy |
| MA 100 | $2.56 | Buy | $2.70 | Sell |
| MA 200 | $3.17 | Sell | $3.10 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.27 | Neutral |
| Stoch RSI (14) | 68.90 | Neutral |
| CCI (20) | -11.82 | Neutral |
| Williams %R (14) | -44.44 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -6.83 | Sell |
| Bollinger %B (20,2) | 0.46 | Neutral |
| Stochastic %K (14) | 55.56 | Neutral |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | -0.09 | Sell |
| Ultimate (7,14,28) | 60.36 | Neutral |
| Momentum (10) | 0.05 | Buy |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 2.51 | Buy |
| ADX (14) | 13.55 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture shows bearish sentiment currently. The RSI(14) is 40, and the price sits below the SMA50 of $2.54 while remaining well below the SMA200 of $3.19. The stock trades within a 30-day range of $1.99 to $3.01, with a nearby support at $2.27 and resistance at $2.87.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.68 | $2.59 | $3.60 | 0% | Neutral | |
| $2.50 | $3.19 | $4.33 | +23% | Bullish | |
| $2.66 | $3.50 | $4.95 | +35% | Bullish | |
| $2.42 | $3.27 | $4.76 | +26% | Bullish | |
| $2.35 | $3.26 | $4.87 | +26% | Bullish | |
| $2.49 | $3.52 | $5.38 | +36% | Bullish | |
| $2.84 | $4.09 | $6.39 | +58% | Bullish | |
| $3.20 | $4.70 | $7.48 | +81% | Bullish | |
| $3.14 | $4.69 | $7.60 | +81% | Bullish | |
| $3.14 | $4.78 | $7.86 | +85% | Bullish | |
| $4.21 | $6.93 | $12.18 | +167% | Bullish | |
| $5.74 | $10.84 | $20.99 | +318% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.68 | $2.59 | $3.04 | +0.00% |
| June 2026 | $2.19 | $2.57 | $3.11 | -0.60% |
| July 2026 | $2.26 | $2.69 | $3.29 | +4.39% |
| August 2026 | $2.29 | $2.75 | $3.41 | +2.18% |
| September 2026 | $2.22 | $2.68 | $3.36 | -2.38% |
| October 2026 | $2.22 | $2.69 | $3.40 | +0.52% |
| November 2026 | $2.30 | $2.80 | $3.56 | +3.90% |
| December 2026 | $2.30 | $2.81 | $3.60 | +0.48% |
Click any year to see its month-by-month CLVT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CLVT is projected to trade between $1.68 and $3.60, averaging $2.59 — a potential gain of 0% from today's $2.59. Price action looks broadly range-bound.
Clarivate Plc's 2027 outlook centres on $3.19, within a $2.50 to $4.33 range. That is up +23% on the projected 2026 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, CLVT could reach as high as $4.95, with a base case around $3.50 and support toward $2.66 — roughly +35% from $2.59. Momentum favours further upside here.
Expect CLVT to range from $2.42 to $4.76 through 2029. The $3.27 average target implies a +26% move from current prices. That is -7% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The CLVT price prediction for 2030 points to an average of $3.26 (low $2.35, high $4.87) — a potential gain of +26% on today's $2.59. Momentum favours further upside here.
In 2031, CLVT is projected to trade between $2.49 and $5.38, averaging $3.52 — a potential gain of +36% from today's $2.59. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Clarivate Plc's 2032 outlook centres on $4.09, within a $2.84 to $6.39 range. That is up +16% on the projected 2031 average. That marks a +58% change versus current levels. Momentum favours further upside here.
By 2033, CLVT could reach as high as $7.48, with a base case around $4.70 and support toward $3.20 — roughly +81% from $2.59. Buyers look set to stay in control over this stretch.
Expect CLVT to range from $3.14 to $7.60 through 2034. The $4.69 average target implies a +81% move from current prices. That is 0% versus the projected 2033 average. Momentum favours further upside here.
The CLVT price prediction for 2035 points to an average of $4.78 (low $3.14, high $7.86) — a potential gain of +85% on today's $2.59. Buyers look set to stay in control over this stretch.
In 2040, CLVT is projected to trade between $4.21 and $12.18, averaging $6.93 — a potential gain of +167% from today's $2.59. That is up +45% on the projected 2035 average. Momentum favours further upside here.
Clarivate Plc's 2050 outlook centres on $10.84, within a $5.74 to $20.99 range. That is up +56% on the projected 2040 average. That marks a +318% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in CLVT today (≈ 386.100386 CLVT) could be worth
$4,183.5
+$3,183.5 (+318%) by 2050 · US Dollar
Based on the average projected CLVT price of $10.84 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLVTwould be worth at today's price.
$1,000 invested in CLVT on May 27, 2025 (≈ 240.384624 CLVT) would be worth
$622.6
-$377.4 (-37.7%) today · 0.62× · US Dollar
Based on a CLVT entry price of $4.16 vs. today's $2.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.46 | $1,052.85 | +5.3% |
| 1 month ago | $2.46 | $1,052.85 | +5.3% |
| 3 months ago | $2.4 | $1,079.17 | +7.9% |
| 6 months ago | $3.76 | $688.83 | -31.1% |
| 1 year ago | $4.16 | $622.6 | -37.7% |
| All time (5.0y) ago | $29.89 | $86.65 | -91.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLVT forecast.
Our base-case forecast reaches $5.20 around 2040.
Implied market cap at $5.20: $3.32B
The multi-year forecast paints a bullish trajectory, with the average price edging higher through the period. In 2026 the avg is $2.45, expanding through 2027 to $3.03 and 2028 to $3.33, then to $3.05 in 2029 and $3.05 in 2030, with 2031 at $3.31 and 2032 at $3.79. The forecast continues to rise, with 2033 at $4.39, 2034 at $4.39, and 2035 at $4.42.
By 2040, the avg is $6.43 with a max of $11.38 and ROI of 162.3%, and by 2050, the avg reaches $9.88 with a max of $19.29 and ROI of 303.3%, all with bullish sentiment. The longer-horizon path is subject to market volatility, as indicated by an annualized volatility of 60%, and outcomes are not guaranteed. 2030 specifically shows an avg of $3.05, max $4.59, min $2.20, ROI 24.6%, with bullish sentiment, while 2040 and 2050 show progressively higher upside potential.
Tap a question to reveal the answer.
In 2030 the forecast shows an avg price of $3.05, a max of $4.59, and a min of $2.20, with an ROI of 24.6% and a bullish sentiment.
The long-range forecast depicts a bullish path with rising averages and upside ROIs, reaching as high as 303.3% by 2050. However, 2026 is neutral and the near term shows volatility and risk, so outcomes are estimates, not guarantees.
Yes. The forecast shows a 2040 max of $11.38 and a 2050 max of $19.29, indicating the potential to surpass $10 by 2040 or later.
The current price is $2.45 and the market cap is $1.57B.
The stock has a bearish sentiment with RSI(14) at 40. The 30-day range is $1.99 to $3.01, with a support at $2.27 and a resistance at $2.87; SMA50 is $2.54 and SMA200 is $3.19.
Clarivate Plc Community Discussion
0Share your Clarivate Plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.